microdosing semaglutide for perimenopause GLP-1 Perimenopause: Why Lower Doses Might Be Better Semaglutide for Perimenopause Weight Gain

Ryan Wood to explore whether Tirzepatide could support your journey toward better movement, energy, and health

Mosenzon O, Capehorn MS, De Remigis A, Rasmussen S, Weimers P, Rosenstock J

Contact your GP urgently, call NHS 111, or go to A&E if you experience: Severe, persistent abdominal pain (potential pancreatitis) Right upper abdominal pain, fever or jaundice (possible gallbladder disease) Persistent vomiting preventing fluid intake Signs of dehydration or reduced urine output (possible acute kidney injury) Visual changes or eye symptoms (especially if you have diabetic retinopathy) Symptoms of hypoglycaemia (particularly if taking insulin or sulfonylureas) Your blood glucose levels may rise as Ozempic's effects wane, particularly if you have type 2 diabetes

Nie Z-J, Zhang Y-G, Chang Y-H, Li Q-Y, Zhang Y-L

Clinical trials show that weight loss continues to build over time, with the most significant results seen between 36 and 72 weeks of consistent treatment